Clinical Trial Update: Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

Phase 1 trial of nivolumab in combination with plinabulin for metastatic non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Plinabulin (plinabulin)
• nivolumab (nivolumab)

Snippet

Sponsor: Lyudmila Bazhenova, M.D. | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 1 | Status: COMPLETED